Altered mitochondrial function, iron metabolism and glutathione levels in Parkinson's disease
- PMID: 8333254
Altered mitochondrial function, iron metabolism and glutathione levels in Parkinson's disease
Abstract
The mechanisms underlying dopamine cell death in substantia nigra in Parkinson's disease remain unknown. Current concepts of this process suggest the involvement of free radical species and oxidative stress. Indeed, in postmortem tissues from patients dying with Parkinson's disease there is evidence for inhibition of complex I of the mitochondrial respiratory chain, altered iron metabolism and decreased levels of reduced glutathione. However, alterations in iron levels in substantia nigra are not specific to Parkinson's disease but also occur in other basal ganglia degenerative diseases. So, alterations in iron may be a response to, rather than a cause of nigral cell death. This is further suggested by a failure to find any alterations in iron metabolism in cases of incidental Lewy body disease (presymptomatic Parkinson's disease). Similarly, in these tissues no significant alteration in complex I activity is apparent. However, there is a reduction in the levels of reduced glutathione in substantia nigra in incidental Lewy body disease of the same magnitude as occurs in advanced Parkinson's disease. This would suggest that alterations in glutathione function are an early marker of pathology in Parkinson's disease and may be a clue to the primary cause of nigral cell death.
Similar articles
-
Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The Royal Kings and Queens Parkinson's Disease Research Group.Ann Neurol. 1992;32 Suppl:S82-7. doi: 10.1002/ana.410320714. Ann Neurol. 1992. PMID: 1510385 Review.
-
What process causes nigral cell death in Parkinson's disease?Neurol Clin. 1992 May;10(2):387-403. Neurol Clin. 1992. PMID: 1584181 Review.
-
Oxidative mechanisms in nigral cell death in Parkinson's disease.Mov Disord. 1998;13 Suppl 1:24-34. Mov Disord. 1998. PMID: 9613715 Review.
-
Clues to the mechanism underlying dopamine cell death in Parkinson's disease.J Neurol Neurosurg Psychiatry. 1989 Jun;Suppl(Suppl):22-8. doi: 10.1136/jnnp.52.suppl.22. J Neurol Neurosurg Psychiatry. 1989. PMID: 2666576 Free PMC article. Review.
-
Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease.Ann Neurol. 1994 Jan;35(1):38-44. doi: 10.1002/ana.410350107. Ann Neurol. 1994. PMID: 8285590
Cited by
-
The Role of Oxidative Stress in Parkinson's Disease.Antioxidants (Basel). 2020 Jul 8;9(7):597. doi: 10.3390/antiox9070597. Antioxidants (Basel). 2020. PMID: 32650609 Free PMC article. Review.
-
Alpha-synuclein deficiency leads to increased glyoxalase I expression and glycation stress.Cell Mol Life Sci. 2011 Feb;68(4):721-33. doi: 10.1007/s00018-010-0483-7. Epub 2010 Aug 14. Cell Mol Life Sci. 2011. PMID: 20711648 Free PMC article.
-
Glutathione depletion in immortalized midbrain-derived dopaminergic neurons results in increases in the labile iron pool: implications for Parkinson's disease.Free Radic Biol Med. 2009 Mar 1;46(5):593-8. doi: 10.1016/j.freeradbiomed.2008.11.012. Epub 2008 Dec 3. Free Radic Biol Med. 2009. PMID: 19118623 Free PMC article.
-
Antioxidant and anti-apoptotic activity of vasoactive intestinal peptide (VIP) against 6-hydroxy dopamine toxicity in the rat corpus striatum.J Mol Neurosci. 2012 Jan;46(1):51-7. doi: 10.1007/s12031-011-9618-z. Epub 2011 Aug 18. J Mol Neurosci. 2012. PMID: 21850490
-
Quantitative mapping of reversible mitochondrial Complex I cysteine oxidation in a Parkinson disease mouse model.J Biol Chem. 2011 Mar 4;286(9):7601-8. doi: 10.1074/jbc.M110.190108. Epub 2011 Jan 1. J Biol Chem. 2011. PMID: 21196577 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
